ASP Isotopes Inc. announced that its wholly‑owned subsidiary Quantum Leap Energy has entered into a collaboration with the University of Bristol to design a state‑of‑the‑art lithium laser research facility in the United Kingdom. The partnership will see the university lead a four‑month feasibility study, including detailed engineering specifications, safety reviews, and design work that could culminate in a RIBA Stage 4 technical design. The facility would support Quantum Leap Energy’s goal of advancing high‑assay low‑enriched uranium (HALEU) and lithium‑6 enrichment for next‑generation nuclear reactors.
The collaboration expands Quantum Leap Energy’s laser‑enrichment program and could accelerate the development of high‑purity lithium‑6 for fusion and advanced fission applications, opening a new revenue stream for ASP Isotopes. Dr. Ryno Pretorius, CEO of Quantum Leap Energy, said: "This collaboration with the University of Bristol represents a pivotal step forward in our mission to advance nuclear fuel technology."
Dr. Ryno Pretorius also noted: "Bristol University's world‑class expertise in research facility design, coupled with their team's deep understanding of lithium and critical elements in nuclear technology make them an ideal partner for this ambitious project."
ASP Isotopes has a history of missed EPS estimates and negative profitability margins. In Q3 2025 the company reported an EPS of –$0.15 versus an estimate of –$0.10, while revenue of $4.89 million exceeded the estimate of $2.25 million. The company’s Altman Z‑Score is distressed, and its stock has declined over the past six months despite strong revenue growth.
The announcement was well received by investors, reflecting confidence in the company’s strategic direction. The collaboration follows the company’s recent ahead‑of‑schedule drilling for the Renergen Helium Project, which further demonstrates operational execution.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.